Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.59 |
| ▸ | PPARG | P37231 | 8/20 | 0.59 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.59 |
| ▸ | MAPT | P10636 | 5/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.59 |
| ▸ | OXER1 | Q8TDS5 | 4/20 | 0.59 |
| ▸ | RXRA | P19793 | 2/20 | 0.59 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.46 |
| ▸ | F7 | P08709 | 7/20 | 0.45 |
| ▸ | F3 | P13726 | 7/20 | 0.45 |
| ▸ | PPARD | Q03181 | 6/20 | 0.45 |
| ▸ | PPARA | Q07869 | 6/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2575707 | 1.00 | ALDH1A1 (0.59) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL8017585 | 1.00 | ALDH1A1 (0.59) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL27948496 | 0.98 | ALDH1A1 (0.63) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL20528003 | 0.98 | ALDH1A1 (0.63) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL14317851 | 0.98 | ALDH1A1 (0.63) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL29574065 | 0.86 | ALDH1A1 (0.61) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL28742696 | 0.85 | ALDH1A1 (0.66) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL10823290 | 0.83 | MAPT (0.54) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL10823289 | 0.83 | MAPT (0.54) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL15153051 | 0.83 | MAPT (0.67) | ALDH1A1PPARGCYP19A1MAPTFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240050337-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2024-02-15 | — | — | US | claimed |
| EP-4096618-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2022-12-07 | — | — | EP | claimed |
| WO-2022122143-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | claimed |
| US-10336966-B2 | Fragrance compositions and uses thereof | THE PROCTER & GAMBLE COMPANY (US) | 2019-07-02 | — | — | US | claimed |
| US-20190155975-A9 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2019-05-23 | — | — | US | claimed |
| US-10113140-B2 | Freshening compositions and devices comprising same | THE PROCTER & GAMBLE COMPANY (US) | 2018-10-30 | — | — | US | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| US-20180004875-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2018-01-04 | — | — | US | claimed |
| US-20170333591-A9 | ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2017-11-23 | — | — | US | claimed |
| US-9814661-B2 | Fragrance compositions | THE PROCTER & GAMBLE COMPANY (US) | 2017-11-14 | — | — | US | claimed |
| WO-2016049396-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160090555-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049397-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049394-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| EP-2961374-A1 | FRAGRANCE COMPOSITIONS | The Procter & Gamble Company (US) | 2016-01-06 | — | — | EP | claimed |
| WO-2015089246-A1 | FRAGRANCE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-18 | — | — | WO | claimed |
| US-20150164764-A1 | Fragrance Compositions | THE PROCTER & GAMBLE COMPANY | 2015-06-18 | — | — | US | claimed |
| EP-0773209-B1 | Unsaturated esters | GIVAUDAN ROURE INT (CH) | 2000-01-26 | — | — | EP | claimed |
| US-5837671-A | ETHYL OCTADIENOATE FOR TASTE AND ODOR | GIVAUDAN-ROURE (INTERNATIONAL) SA (CH) | 1998-11-17 | — | — | US | claimed |
| EP-0773209-A1 | Unsaturated esters | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1997-05-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150164764-A1 | Fragrance Compositions | OGG1, ALKBH5, MYB | ALDH1A1 1367/4885PPARG 743/4885CYP19A1 439/4885 |
| US-10336966-B2 | Fragrance compositions and uses thereof | CUTA, DPM1, PLIN5 | ALDH1A1 1263/4885PPARG 1576/4885CYP19A1 222/4885 |
| US-20240050337-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | OR10J3, OR51E2, MAL2 | ALDH1A1 27/4885PPARG 3888/4885CYP19A1 935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.